<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220725055553N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-02-17</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>he Effect of Mindfulness-Based Cognitive Behavioral Therapy on Emotion and Cognitive Function in Patients with Mood Disorders</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of cognitive behavioral therapy based on mindfulness on emotional regulation, metacognitive ability, and cognitive flexibility in patients with mood disorders .</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>68</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/88782</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: In this study, simple individual-level randomization will be used. After eligibility is confirmed and the baseline assessment is completed, each participant will be randomly assigned to either the intervention or control group. The random sequence will be generated by an independent statistician using SPSS software, and the allocation list will be kept confidential by the statistician.
For allocation concealment, a central allocation method will be used: once the participant’s baseline information is fully recorded, the implementing researcher will contact the statistician to obtain the assigned group. Therefore, the implementer will have no prior knowledge of the participant’s group.
Additionally, the person collecting the questionnaires will be blinded to the participants’ group assignments, and the data will be provided to the statistical analyst in a coded form (Groups 1 and 2) to ensure analyses are conducted without knowledge of the intervention type. The codes will only be revealed after the analysis is completed, Blinding description: To ensure impartiality, data analysis will be conducted in a single-blind manner. Raw data, after group coding with neutral labels (e.g., Group 1 and Group 2) and without disclosure of the type of intervention, will be provided to the analyst. The analyst will perform all statistical tests based solely on these codes and will remain unaware of the allocation of each group to the intervention or control until the initial analysis is completed. This process prevents bias in the analysis.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Bipolar affective disorder.</hc_freetext>
      <i_freetext>Intervention 1: The intervention for the experimental group consists of a structured psychological protocol that combines cognitive-behavioral therapy (CBT) and mindfulness exercises (Mindfulness-Based Cognitive Therapy, MBCT). The primary goal of this intervention is to help patients with mood disorders (depression or bipolar disorder) increase awareness of their present-moment thoughts and feelings without judgment or automatic reactions. The intervention is delivered in the form of 8 in-person group sessions, each lasting 45 minutes, following the standard MBCT protocol, with sessions held three times per week. The total duration of the intervention is approximately three weeks. Sessions are led by a clinical psychologist trained in MBCT and include theoretical instruction, practical exercises, group discussions, and homework assignments. The session content includes the following:•	Introduction to the concept of mindfulness and its importance in mood and emotion regulation•	Body scan exercises and breathing practices•	Identifying and observing thoughts and feelings as transient phenomena•	Mindfulness practice in daily activities•	Developing a non-judgmental attitude and acceptance without automatic reaction special equipment is required for the intervention other than a group therapy room, chairs, and the ability to play audio files (for some guided meditations). It should be noted that all participants are simultaneously receiving routine psychiatric care at the hospital, and the MBCT intervention is provided as an adjunctive therapy. Intervention 2: Control Group: Participants in this group do not receive any structured mindfulness-based cognitive-behavioral therapy sessions. Their intervention consists of standard routine psychiatric care provided by the hospital. This care includes regular follow-up by the treating psychiatrist for medication management, administration of prescribed psychiatric medications (with names, doses, and frequency according to the physician’s prescription), and routine nursing and environmental care on the ward. No educational programs, structured group therapy sessions, or other specific psychological interventions will be provided to this group during the study period. Like other hospitalized patients, members of this group receive only medical supervision and treatment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Key data include: scores from the Cognitive Emotion Regulation Questionnaire (CERQ), metacognitive ability (Wells Questionnaire), cognitive flexibility (Dennis &amp; Vanderwal), and baseline/demographic data such as age, sex, marital status, and hospitalization history.

When:
The access to de-identified participant data and related documents will begin **6 months after the publication of the study results** and will remain available for **5 years**.

To whom:
Academic Researchers

Conditions:
The de-identified participant data and related documents may be used only for scientific research purposes and secondary analyses related to the study topic. Requests for access to the data must be submitted by independent researchers with a clear research proposal and, upon approval by the ethics committee or the responsible research team, the data will be provided to the requester. Any publication of secondary results must cite the original study, and commercial use of the data is not permitted. Additionally, the requester is required to maintain data confidentiality and must refrain from any attempt to identify study participants.

Where to obtain:
Fatemeh Lohrasebi
Flohrasebi@nm.mui.ac.ir

How to obtain:
After submitting a request for access to the data and documents along with a research proposal, the request will be reviewed by the study team and the ethics committee. Once approved, the de-identified data and documents will be provided to the requester through a secure method. This process typically takes 4 to 8 weeks.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Lohrasebi Nejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar jerib</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 7607</telephone>
        <email>Flohrasebi@nm.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Lohrasebi Nejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar jerib</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 7607</telephone>
        <email>Flohrasebi@nm.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Minimum literacy (ability to read and write)...
Diagnosis of a mood disorder confirmed by a psychiatrist
Hospitalization at Farabi Hospital
Age range between 20 and 50 years.
Written informed consent to participate in the study</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Severe mental disorders (as diagnosed by a psychiatrist) impeding participation in patient education sessions.
history of substance abuse.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F31</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Bipolar disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention for the experimental group consists of a structured psychological protocol that combines cognitive-behavioral therapy (CBT) and mindfulness exercises (Mindfulness-Based Cognitive Therapy, MBCT). The primary goal of this intervention is to help patients with mood disorders (depression or bipolar disorder) increase awareness of their present-moment thoughts and feelings without judgment or automatic reactions. The intervention is delivered in the form of 8 in-person group sessions, each lasting 45 minutes, following the standard MBCT protocol, with sessions held three times per week. The total duration of the intervention is approximately three weeks. Sessions are led by a clinical psychologist trained in MBCT and include theoretical instruction, practical exercises, group discussions, and homework assignments. The session content includes the following:•	Introduction to the concept of mindfulness and its importance in mood and emotion regulation•	Body scan exercises and breathing practices•	Identifying and observing thoughts and feelings as transient phenomena•	Mindfulness practice in daily activities•	Developing a non-judgmental attitude and acceptance without automatic reaction special equipment is required for the intervention other than a group therapy room, chairs, and the ability to play audio files (for some guided meditations). It should be noted that all participants are simultaneously receiving routine psychiatric care at the hospital, and the MBCT intervention is provided as an adjunctive therapy.</i_keyword>
      <i_keyword>Control Group: Participants in this group do not receive any structured mindfulness-based cognitive-behavioral therapy sessions. Their intervention consists of standard routine psychiatric care provided by the hospital. This care includes regular follow-up by the treating psychiatrist for medication management, administration of prescribed psychiatric medications (with names, doses, and frequency according to the physician’s prescription), and routine nursing and environmental care on the ward. No educational programs, structured group therapy sessions, or other specific psychological interventions will be provided to this group during the study period. Like other hospitalized patients, members of this group receive only medical supervision and treatment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Emotion regulation refers to an individual’s ability to recognize, manage, and control their emotions in a way that responses are appropriate to the context, goals, and social situations. This skill includes identifying emotions, modulating their intensity and duration, and selecting suitable strategies to cope with negative emotions or enhance positive ones. Emotion regulation plays a key role in mental health, decision-making, cognitive flexibility, and interpersonal relationships. Timepoint: pre and post intervention. Method of measurement: Gross &amp; John’s Cognitive Emotion Regulation Questionnaire.</prim_outcome>
      <prim_outcome>Metacognitive ability refers to an individual’s skill in awareness, monitoring, and control of their own cognitive processes. This ability includes recognizing one’s thoughts and beliefs, understanding cognitive strengths and limitations, and managing strategies for problem-solving and decision-making. Metacognition plays a key role in learning, cognitive flexibility, self-regulation, and mental health enhancement. Timepoint: pre and post intervention. Method of measurement: Wells’ Metacognitions Questionnaire.</prim_outcome>
      <prim_outcome>Cognitive flexibility refers to an individual’s ability to adapt their thoughts, attitudes, and behaviors according to new or unexpected situations. This skill includes the capacity to view problems from different perspectives, select alternative strategies, and adjust to environmental changes, playing a key role in problem-solving, decision-making, and stress management. Timepoint: pre and post intervention. Method of measurement: Dennis &amp; Vander Wal’s Cognitive Flexibility Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-01-20</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Hezar Jarib Street, Isfahan University of Medical Sciences Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
